These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2239454

  • 1. Brain glucose metabolism in Parkinson's disease.
    Metter EJ, Kuhl DE, Riege WH.
    Adv Neurol; 1990; 53():135-9. PubMed ID: 2239454
    [No Abstract] [Full Text] [Related]

  • 2. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
    Martin WR, Stoessl AJ, Adam MJ, Ammann W, Bergstrom M, Harrop R, Laihinen A, Rogers JG, Ruth TJ, Sayre CI.
    Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398
    [No Abstract] [Full Text] [Related]

  • 3. Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
    Przedborski S, Goldman S, Giladi N, Dhawan V, Takikawa S, Hildebrand J, Fahn S, Eidelberg D.
    Adv Neurol; 1993; 60():501-5. PubMed ID: 8420178
    [No Abstract] [Full Text] [Related]

  • 4. Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.
    Sasaki M, Ichiya Y, Hosokawa S, Otsuka M, Kuwabara Y, Fukumura T, Kato M, Goto I, Masuda K.
    Ann Nucl Med; 1992 Nov; 6(4):241-6. PubMed ID: 1489634
    [Abstract] [Full Text] [Related]

  • 5. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia.
    van Gorp WG, Mandelkern MA, Gee M, Hinkin CH, Stern CE, Paz DK, Dixon W, Evans G, Flynn F, Frederick CJ.
    J Neuropsychiatry Clin Neurosci; 1992 Nov; 4(3):280-7. PubMed ID: 1498579
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y, Kato T, Tadokoro M, Sobue G.
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [Abstract] [Full Text] [Related]

  • 8. Functional brain imaging in late-life depression and dementia.
    Kumar A.
    J Clin Psychiatry; 1993 Nov; 54 Suppl():21-5. PubMed ID: 8270594
    [Abstract] [Full Text] [Related]

  • 9. PET: studies in dementia.
    Frackowiak RS.
    Psychiatry Res; 1989 Sep; 29(3):353-5. PubMed ID: 2692056
    [No Abstract] [Full Text] [Related]

  • 10. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T, Ferris SH, Wolf AP, De Leon MJ, Christman DR, Reisberg B, Alavi A, Fowler JS, George AE, Reivich M.
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract] [Full Text] [Related]

  • 11. Determinations of cerebral glucose utilization in dementia using positron emission tomography.
    Kuhl DE, Metter EJ, Riege WH, Hawkins RA.
    Dan Med Bull; 1985 Feb; 32 Suppl 1():51-5. PubMed ID: 3872772
    [No Abstract] [Full Text] [Related]

  • 12. Positron emission tomography as an imaging tool in psychiatric disorders.
    Heiss WD, Pawlik G, Herholz K, Szelies B, Wienhard K.
    Psychiatry Res; 1989 Sep; 29(3):351-2. PubMed ID: 2532752
    [No Abstract] [Full Text] [Related]

  • 13. Cerebral glucose metabolism in epilepsy patients associated with organic brain damage.
    Otsuki T, Nakasato N, Kameyama M, Sato K, Jokura H, Seki K, Yoshimoto T.
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):404-6. PubMed ID: 1762230
    [No Abstract] [Full Text] [Related]

  • 14. Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination.
    Nishiyama K, Mizuno T, Sakuta M, Kurisaki H.
    Adv Neurol; 1993 Jun; 60():479-83. PubMed ID: 8420174
    [Abstract] [Full Text] [Related]

  • 15. Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism.
    Martin PR, Rio D, Adinoff B, Johnson JL, Bisserbe JC, Rawlings RR, Rohrbaugh JW, Stapleton JM, Eckardt MJ.
    J Neuropsychiatry Clin Neurosci; 1992 Jun; 4(2):159-67. PubMed ID: 1627977
    [Abstract] [Full Text] [Related]

  • 16. Reduced regional cerebral metabolic rate for glucose at the terminal stage in a case of late infantile neuronal ceroid lipofuscinosis.
    Fueki N, Iinuma K, Kojima A, Yanai K, Haginoya K, Tada K, Ido T, Ito M.
    J Child Neurol; 1990 Apr; 5(2):98-100. PubMed ID: 2345285
    [Abstract] [Full Text] [Related]

  • 17. Positron emission tomography in dementia.
    Friedland RP.
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract] [Full Text] [Related]

  • 18. Glucose metabolism in the caudate nuclei of patients with eating disorders, measured by PET.
    Krieg JC, Holthoff V, Schreiber W, Pirke KM, Herholz K.
    Eur Arch Psychiatry Clin Neurosci; 1991 Dec; 240(6):331-3. PubMed ID: 1831664
    [Abstract] [Full Text] [Related]

  • 19. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE.
    J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
    [Abstract] [Full Text] [Related]

  • 20. Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: a preliminary report.
    Guze BH, Baxter LR, Schwartz JM, Szuba MP, Mazziotta JC, Phelps ME.
    Psychiatry Res; 1991 Nov; 40(3):195-202. PubMed ID: 1780392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.